Mirae Asset Global ETFs Holdings’s ArriVent BioPharma AVBP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$293K Sell
13,403
-4,143
-24% -$90.5K ﹤0.01% 2080
2025
Q1
$325K Buy
17,546
+432
+3% +$8K ﹤0.01% 2081
2024
Q4
$456K Buy
17,114
+1,327
+8% +$35.4K ﹤0.01% 1966
2024
Q3
$371K Buy
15,787
+10,906
+223% +$256K ﹤0.01% 2065
2024
Q2
$90.5K Buy
+4,881
New +$90.5K ﹤0.01% 2605